TrialThe New England journal of medicine2020
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
Michael Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,041 papers cite itlatest 60 shown
this paperpooled ittrialcites it